BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28771721)

  • 21. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
    Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
    Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly r(C) binding protein (PCBP) 1 expression is regulated by the E3 ligase UBE4A in thyroid carcinoma.
    Zhang MP; Zhang WS; Tan J; Zhao MH; Lian LJ; Cai J
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28963376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer.
    Inoue Y; Itoh Y; Sato K; Kawasaki F; Sumita C; Tanaka T; Morishita D; Hayashi H
    Curr Cancer Drug Targets; 2016; 16(2):110-8. PubMed ID: 26560121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-κB activation, and promotion of cell invasion and angiogenesis.
    Ding X; Xu J; Wang C; Feng Q; Wang Q; Yang Y; Lu H; Wang F; Zhu K; Li W; Yan Q; Gao SJ; Lu C
    Cell Death Differ; 2019 Oct; 26(10):1970-1986. PubMed ID: 30670829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of HER-2 via siRNA interference promotes apoptosis and decreases metastatic potential of SKOV‑3 human ovarian carcinoma cells.
    Lu YM; Rong ML; Shang C; Wang N; Li X; Zhao YY; Zhang SL
    Oncol Rep; 2013 Mar; 29(3):1133-9. PubMed ID: 23292493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
    Zhao J; Yang C; Guo S; Wu Y
    Int J Clin Exp Pathol; 2015; 8(9):10784-91. PubMed ID: 26617790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer.
    Han X; Zhou Y; You Y; Lu J; Wang L; Hou H; Li J; Chen W; Zhao L; Li X
    Cell Biol Int; 2017 Apr; 41(4):405-414. PubMed ID: 28150354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-9 promotes multiple myeloma progression by regulating TRIM56/NF-κB pathway.
    Huang G; Liu X; Zhao X; Zhao J; Hao J; Ren J; Chen Y
    Cell Biol Int; 2019 Nov; 43(11):1223-1233. PubMed ID: 30637864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS; Choi KC; Hwang KA
    Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein.
    Yang X; Zhang Y; Xue Z; Hu Y; Zhou W; Xue Z; Liu X; Liu G; Li W; Liu X; Li X; Han M; Wang J
    J Exp Clin Cancer Res; 2022 Dec; 41(1):336. PubMed ID: 36471347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tripartite Motif 16 Inhibits the Migration and Invasion in Ovarian Cancer Cells.
    Tan H; Qi J; Chu G; Liu Z
    Oncol Res; 2017 Apr; 25(4):551-558. PubMed ID: 27737724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
    Wang XL; Shi WP; Shi HC; Lu SC; Wang K; Sun C; He JS; Jin WG; Lv XX; Zou H; Shu YS
    Oncotarget; 2016 Dec; 7(49):81527-81540. PubMed ID: 27829229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
    Kenda Suster N; Smrkolj S; Virant-Klun I
    J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The E3 ligase TRIM56 is a host restriction factor of Zika virus and depends on its RNA-binding activity but not miRNA regulation, for antiviral function.
    Yang D; Li NL; Wei D; Liu B; Guo F; Elbahesh H; Zhang Y; Zhou Z; Chen GY; Li K
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007537. PubMed ID: 31251739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
    Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
    Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
    Lv ZD; Kong B; Liu XP; Jin LY; Dong Q; Li FN; Wang HB
    J Cell Mol Med; 2016 May; 20(5):864-73. PubMed ID: 26820102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.
    Chen A; Wong CS; Liu MC; House CM; Sceneay J; Bowtell DD; Thompson EW; Möller A
    Oncotarget; 2015 Jan; 6(2):862-73. PubMed ID: 25528765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.